Christopher Bunick, MD, PhD: The Future of Small Molecule Drugs in Dermatology

July 20, 2026

Dr. Bunick examines the scientific principles shaping the future of small molecule development in dermatology, focusing on how thoughtful drug design can improve efficacy, safety, and patient outcomes. He outlines 4 key pillars of development—mechanism of action, precision chemistry, tissue exposure, and clinical impact—and illustrates how these concepts are influencing advances in therapies targeting immune-mediated skin diseases. Dr. Bunick also discusses innovations such as targeted protein degraders, covalent small molecule inhibitors, and optimized drug delivery systems, emphasizing how these approaches may expand future treatment options. He concludes by highlighting the importance of understanding these design principles when evaluating emerging therapies and translating the science into improvements in patient care.

MORE 2026 AAD INNOVATION ACADEMY CONFERENCE COVERAGE:

Peter Lio, MD: Expanding Career Opportunities in Dermatology

Dr. Lio explores how dermatologists can expand their impact beyond traditional one-on-one patient care by pursuing entrepreneurial and professional opportunities across the healthcare landscape. He

Tina Bhutani, MD, MAS: Inflammatory Skin Disorders in Skin of Color

Dr. Bhutani discusses the unique presentation of inflammatory skin diseases in patients with skin of color, highlighting important clinical considerations for psoriasis, atopic dermatitis, and

Paradi Mirmirani, MD: Hair Loss During Menopause

Dr. Mirmirani discusses hair loss during menopause, an often overlooked concern affecting millions of women every year as they transition through midlife. She outlines a

Hilary Baldwin, MD, and Julie Harper, MD: Updates in the Treatment Landscape of Acne and Rosacea

Drs. Baldwin and Harper share clinical updates on the management of acne and rosacea, highlighting evolving treatment strategies and emerging therapies. Dr. Harper discusses a

Nada Elbuluk, MD: Pearls for Pigmentary Disorders in Skin of Color

Dr. Elbuluk discusses practical approaches to evaluating and treating hyperpigmentation, hypopigmentation, and depigmentation in patients with skin of color, emphasizing that accurate diagnosis is the

Diego Ruiz Dasilva, MD: Challenging the Status Quo of Lab Monitoring in Dermatology

Dr. Dasilva discusses the importance of challenging longstanding monitoring practices across dermatology, encouraging clinicians to re-evaluate routine testing as new data become available. He reviews

Steven Daveluy, MD: Laughter Yoga for Stress and Wellbeing

Dr. Daveluy discusses laughter yoga, a practice based on the idea that the brain responds similarly to genuine and intentional laughter, allowing individuals to experience

Amy McMichael, MD: Building a Successful Dermatology Department

Dr. McMichael shares practical leadership insights for building and sustaining a successful dermatology department. She highlights the importance of establishing a strong departmental culture in

Jennifer Hsiao, MD: Off-Label Approaches for Recalcitrant Hidradenitis Suppurativa

Dr. Hsiao discusses practical off-label strategies for managing recalcitrant hidradenitis suppurativa, emphasizing strategies for patients with persistent disease despite standard therapy. She highlights 3 key

JCAD Archives